InhaTarget is looking for a COO

InhaTarget Therapeutics, a spin-off of ULB, specialized in the development of innovative and targeted dry powders for inhalation (DPI) is looking for a Chief Operation Officer. Interested? Please find the job offering and contact details here.

Read more

Minoryx Therapeutics extends its activities in Belgium

Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announced the creation of a fully owned subsidiary in Belgium. The new office, located in Brussels South Biopark (Charleroi), is due to launch operations this month.

“We are very excited to be expanding our operations to Belgium, benefiting from local experience in growing biotech companies as well as starting a relationship with Belgian VCs and public investors,” said Marc Martinell, CEO of Minoryx.

Please find the press release here

Read more